[1] Ding Q et al., A TALEN genome-editing system for generating human stem cell-based disease models. Cell stem cell, 2013, 12(2): 238-251.
[2] Liu B et al. CRISPR/Cas9: a powerful tool for identification of new targets for cancer treatment. Drug Discov-ery Today. 2019, 24(4): 955-970.
[3] Ivics Z et al. Transposon-mediated genome manipulation in vertebrates. Nature Methods. 2009, 6(6):415-22.
[4] Manis JP. Knock out, knock in, knock down--genetically manipulated mice and the Nobel Prize. The New England Jour-nal of Medicine. 357 (24): 2426–2429.
[5] Moore CB et al. Short hairpin RNA (shRNA): Design, Delivery and Assessment of Gene Knockdown. Methods Mol Biol. 2010, 629: 141-158.
[6] Nagy A. Cre recombinase: the universal reagent for genome tailoring. Genesis. 2000, 26(2): 99–109.
[7] Biliouris K et al. Stochastic simulations of the tetracycline operon. BMC Syst Biol. 2011, 5(9): 1-19
[8] Demeestere I et al. Orthotopic and heterotopic ovarian tissue transplantation. Human Reproduction Update, 2009, 15(6): 649-665.
[9] Morton CL et al. Establishment of human tumor xenografts in immunodeficient mice. Nature Protocols.
2007, 2 (2): 247–50.
[10] Lai Y et al. Current status and perspectives of patient-derived xenograft models in cancer research. Journal of Hematolo-gy & Oncology. 2017, 10(1): 106.
[11] Denayer T et al. Animal models in translational medicine: Validation and prediction. New Horizons in Translational Med-icine 2. 2014: 5-11.
[12] Dvorak HF. Vascular Permeability Factor/Vascular Endothelial Growth Factor: A Critical Cytokine in Tumor Angiogenesis and a Potential Target for Diagnosis and Therapy. Journal of Clinical Oncology, 2002, 20(21):
4368–4380.
[13] Sarika A et al. Anti-inflammatory activity of Lactobacillus on carrageenan-induced paw edema in male wistar rats. International Journal of Inflammation. 2012, 1: 752015.
[14] Zhang J et al. Autophagy and mitochondrial dysfunction in adjuvant-arthritis rats treatment with resvera-trol. Sci Rep. 2016, 6: 32928.
[15] Elliott G et al. Defining the antigen determinant for T-cell-mediated contact dermatitis using p-phenylene-diamine: a gateway to chemical immunology. Journal of Investigative Dermatology. 2010, 130(3): 641-3.
[16] Van der Fits L et al. Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis. J. Immunol. 2009, 182(9): 5836-5845.
[17] Xia XC et al. Mycoepoxydiene inhibits antigen-stimulated activation of mast cells and suppresses IgE-medi-ated anaphy-laxis in mice. International Immunopharmacology. 2013, 17(2): 336-341.
[18] Jackson AR et al. Anandamide attenuates Th-17 cell-mediated delayed-type hypersensitivity response by triggering IL-10 production and consequent microRNA induction. Plos One. 2014, 9(4): e93954.
[19] Zhang H et al. Role of hydrogen sulfide in cecal ligation and puncture-induced sepsis in the mouse. Amer-ican Journal of Physiology Lung Cellular & Molecular Physiology. 2006, 290(6): L1193.
[20] Tamara S et al. Marine compounds with therapeutic potential in Gram-negative sepsis. Marine Drugs.
인간의 질병을 가진 동물 모델 이제욱 Page 28 / 31 2013, 11(6): 2216-2229.
[21] Restagno D et al. Mice survival and plasmatic cytokine secretion in a “Two Hit” model of sepsis depend on intratracheal Pseudomonas aeruginosa bacterial load. PloS one. 2016, 11(8): e0162109.
[22] Song H et al. Phenotypic characterization of type II collagen-induced arthritis in Wistar rats. Experimental
& Therapeutic Medicine. 2015, 10(4):1483.
[23] Yimam M et al. Up1304, a botanical composition containing two standardized extracts of curcuma lon-gaandmorus alba, mitigates pain and inflammation in adjuvant-induced arthritic rats. Pharmacognosy Re-search. 2016, 8(2): 112-117.
[24] Nandakumar KS et al. Efficient promotion of collagen antibody induced arthritis (CAIA) using four mono-clonal antibod-ies specific for the major epitopes recognized in both collagen induced arthritis and rheu-matoid arthritis. Journal of Im-munological Methods. 2005, 304(1-2): 126.
[25] Wu J et al. Streptozotocin-induced type 1 diabetes in rodents as a model for studying mitochondrial mechanisms of diabetic β cell glucotoxicity. Diabetes Metabolic Syndrome & Obesity Targets & Therapy.
2015, 8:181-188.
[26] Aboonabi A et al. Antioxidant effect of pomegranate against streptozotocin-nicotinamide generated oxida-tive stress induced diabetic rats. Toxicology Reports. 2014, 1(2): 915-922.
[27] Davidson EP et al. Differences and similarities in development of corneal nerve damage and peripheral neuropathy and in diet-induced obesity and type 2 diabetic rats. Investigative Ophthalmology & Visual Science. 2014, 55(3): 1222.
[28] Martin-Gronert MS et al. Experimental IUGR and later diabetes. Journal of internal medicine. 2007, 261(5):
437-52.
[29] Kurup S et al. Combined effect of nicotinamide and streptozotocin on diabetic status in partially pancre-atectomized adult BALB/c mice. Hormone & Metabolic Research. 2000, 32(08): 330-334.
[30] Chidrawar VR et al. Anti-obesity effect of Stellaria media methanolic extract in the murine model of cafete-ria diet induced obesity. International Journal of Nutrition, Pharmacology, Neurological Diseases. 2012, 2(2):
576–584.
[31] Sasaki Y et al. Effects of bezafibrate in nonalcoholic steatohepatitis model mice with monosodium gluta-mate-induced metabolic syndrome. European Journal of Pharmacology. 2011, 662(1-3): 1.
[32] Bosnar M et al. Azithromycin inhibits macrophage interleukin-1β production through inhibition of activator protein-1 in lipopolysaccharide-induced murine pulmonary neutrophilia. International Immunopharmacol-ogy. 2011, 11(4): 424-34.
[33] Snider GL et al. Chronic interstitial pulmonary fibrosis produced in hamsters by endotracheal bleomycin.
Lung volumes, volume-pressure relations, carbon monoxide uptake, and arterial blood gas studied. Am Rev Respir Dis. 1978; 117(2):289-97.
[34] Seimetz M et al. Cigarette Smoke-Induced Emphysema and Pulmonary Hypertension Can Be Prevented by Phos-phodiesterase 4 and 5 Inhibition in Mice. Plos One. 2015, 10(6): e0129327.
[35] Quillard T et al. Molecular imaging of atherosclerosis for improving diagnostic and therapeutic develop-ment. Circulation Research. 2012, 111(2): 231.
[36] Sada K et al. Hyperglycemia induces cellular hypoxia through production of mitochondrial ROS followed
인간의 질병을 가진 동물 모델 이제욱 Page 29 / 31 by suppression of aquaporin-1. Plos One. 2016, 11(7): e0158619.
[37] Bonsu KO et al. Review of novel therapeutic targets for improving heart failure treatment based on experi-mental and clinical studies. Therapeutics & Clinical Risk Management. 2016, 12(1): 887-906.
[38] Kumar M et al. Animal models of myocardial infarction: Mainstay in clinical translation. Regul Toxicol Phar-macol. 2016, 76: 221-230.
[39] Yahaya NFM et al. Therapeutic potential of mushrooms in preventing and ameliorating hypertension.
Trends in Food Science & Technology. 2014, 39(2): 104-115.
[40] Franchi F et al. Novel antiplatelet agents in acute coronary syndrome. Nature Reviews Cardiology, 2015, 12(1): 30-47.
[41] Hajrezaie M et al. Biochanin a gastroprotective effects in ethanol-induced gastric mucosal ulceration in rats. Plos One. 2015, 10(3): e0121529.
[42] Vemu B et al. Emu oil offers protection in Crohn's disease model in rats. Bmc Complementary & Alterna-tive Medicine. 2015, 16(1): 1-9.
[43] Zhao L et al. Magnolol, a Natural Polyphenol, Attenuates Dextran Sulfate Sodium-Induced Colitis in Mice.
Molecules. 2017, 22(7): 1218.
[44] Maric I et al. BMP signaling in rats with TNBS-induced colitis following BMP7 therapy. American Journal of Physiology Gastrointestinal & Liver Physiology. 2012, 302(10): G1151.
[45] Kojima R et al. Oxazolone-induced colitis in BALB/C mice: a new method to evaluate the efficacy of thera-peutic agents for ulcerative colitis. Journal of Pharmacological Sciences. 2004, 96(3):307.
[46] Gaggini M et al. Non-Alcoholic Fatty Liver Disease (NAFLD) and Its Connection with Insulin Resistance, Dyslipidemia, Atherosclerosis and Coronary Heart Disease. Nutrients, 2013, 5: 1544-1560.
[47] Scholten D et al. The carbon tetrachloride model in mice. Laboratory Animals. 2015, 49(1 Suppl): 4.
[48] Hewitson TD et al. Small animal models of kidney disease: a review. Kidney Research: Experimental Proto-cols. 2009: 41-57.
[49] Geng W et al. Shenhua Tablet inhibits mesangial cell proliferation in rats with chronic anti-Thy-1 nephritis.
Biological Research. 2016, 49(1): 1-10.
[50] Stojiljkovic N et al. Cytoprotective effect of vitamin C against gentamicin-induced acute kidney injury in rats. Experimental & Toxicologic Pathology Official Journal of the Gesellschaft Für Toxikologische Patholo-gie. 2012, 64(1–2): 69-74.
[51] Mi JS et al. Genistein protects the kidney from cisplatin-induced injury. Kidney International. 2008, 74(12):
1538-47.
[52] Rao KV et al. Nephroprotective effect of ethanolic extract of Azima tetracantha root in glycerol induced acute renal fail-ure in Wistar albino rats. Journal of Traditional & Complementary Medicine. 2015, 6(4): 347.
[53] Wei Q et al. Mouse model of ischemic acute kidney injury: Technical notes and tricks. Ajp Renal Physiol-ogy. 2012, 303(11): F1487.
[54] Tan RZ et al. An optimized 5/6 nephrectomy mouse model based on unilateral kidney ligation and its ap-plication in re-nal fibrosis research. Ren Fail. 2019, 41(1): 555-566.
[55] Liu S et al. Nitro-oleic acid protects against adriamycin-induced nephropathy in mice. Am J Physiol Renal Physiol. 2013, 305(11): F1533-F1541.
인간의 질병을 가진 동물 모델 이제욱 Page 30 / 31 [56] Cox PJ. Cyclophosphamide cystitis—Identification of acrolein as the causative agent. Biochemical
Pharma-cology, 1979, 28(13): 2045–2049.
[57] Golubeva AV et al. The mouse cyclophosphamide model of bladder pain syndrome: tissue characterization, immune profiling, and relationship to metabotropic glutamate receptors. Physiol Rep. 2014, 2(3): e00260.
[58] Choi BH et al. Mast cell activation and response to tolterodine in the rat urinary bladder in a chronic model of intravesi-cal protamine sulfate and bacterial endotoxin-induced cystitis. Molecular Medicine Re-ports. 2014, 10(2): 670.
[59] Chiu PR et al. Vitamin C protects chondrocytes against monosodium iodoacetate-induced osteoarthritis by multiple pathways. International Journal of Molecular Sciences. 2016, 18(1): 38.
[60] Kim JH et al. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkin-son’s disease. Nature, 2002, 418: 50-56
[61] Yao Y et al. An animal model of MERS produced by infection of Rhesus Macaques with MERS Coronavirus.
The Journal of Infectious Diseases, 2014, 209(2): 236-242.
[62] Kim YI et al. Infection and rapid transmission of SARS-CoV-2 in ferrets. Cell Host & Microbe, 2020, 27(5):
704-709.
[63] Shi J et al. Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS–coronavirus 2, Science, 2020, 368(6494): 1016-1020.
[64] Shacklett BL. Can the new humanized mouse model give HIV research a boost. PLoS Med. 2008, 5: e13.
[65] Bao L et al., The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice. Nature, 2020, 583: 830-833.
[66] Dranoff G. Experimental mouse tumour models: what can be learnt about human cancer immunology? Na-ture Reviews Immunology. 2012, 12(1): 61-66.
[67] Shultz LD et al. Humanized mice for immune system investigation: progress, promise and challenges. Na-ture Reviews Immunology. 2012, 12(11): 786-98.
[68] Hartkopf AD et al. PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer. Breast Care. 2016, 11: 385-390.
[69] Xu W et al. The upregulation of immune checkpoint ligand PD-L1 in tumour microenvironment. Scand J Immu-nol. 2014, 80(1): 71-72.
[70] Kim J et al. Human organoids: model systems for human biology and medicine. Nat. Rev. Mol. Cell. Biol.
2020: 1-14.
[71] Zhang YS. The ultimate in personalized medicine: Your Body on a chip. IEEE Spectrum web site
(https://spectrum.ieee.org/biomedical/diagnostics/the-ultimate-in-personalized-medicine-your-body-on-a-chip). (Ac-cessed 08 16, 2020)
[72] Creative-biolabs web site (https://www.creative-biolabs.com/drug-discovery/therapeutics/animal-mod-els.htm). (Accessed ~08 14, 2020)
[73] The Jackson Laboratory web site (https://www.jax.org/). (Accessed ~08 14, 2020)
[74] Charles river web site (https://www.criver.com/products-services/research-models-services). (Accessed ~08 14, 2020)
인간의 질병을 가진 동물 모델 이제욱 Page 31 / 31 저자 이제욱 (오송첨단의료산업진흥재단 신약개발지원센터)
저자는 오송첨단의료산업진흥재단 신약개발지원센터에서 바이오의약품의 유효성, 면역원성, 생체분포, 독성 및 약동/ 약력학 평가 지원 관련 업무를 총괄하고 있다.
약력 (현) 오송첨단의료산업진흥재단 신약개발지원센터, 부장
㈜엔솔테크, 기술이사
㈜메디스커브, 부장
Dana-Farber Cancer Institute, Research fellow UCSF, Post-doctoral fellow
경북대학교, Ph.D.
주 연구 분야 (1) 바이오의약품 개발 (항암면역치료제, 항체, 백신) (2) 바이오의약품 평가 (효능, 독성, 약동/약력학) (3) 바이오의약품 면역원성 평가
The views and opinions expressed by its writers do not necessarily reflect those of the Biological Research Information Center.
이제욱(2020). 인간의 질병을 가진 동물 모델. BRIC View 2020-T31
Available from https://www.ibric.org/myboard/read.php?Board=report&id=3592 (Sep. 08, 2020) Email: member@ibric.org